Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-0600-2021

Drug recall · June 9, 2021

Micardis Tablets recall

Why: Subpotent Drug

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Micardis Tablets, (telmisartan Tablets) 80 mg, 30 ct. per folding cartons, Rx only, NDC 0597-0041-37), Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877

Lots / codes

Lot #860412; SEPT 2022

Quantity
15,198 bottles (30 tablets per bottle)
Company
Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT
Distribution
AR, CO, CT, LA, NC, ND, NH, NJ, OH, PA and PR
Initiated
May 4, 2021 · Voluntary: Firm initiated
Classified
May 28, 2021
Reported
June 9, 2021
Ended
October 14, 2021
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Telmisartan

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.